Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment

J Control Release. 2021 Jan 10:329:624-644. doi: 10.1016/j.jconrel.2020.09.055. Epub 2020 Oct 1.

Abstract

Clinically efficacious medication in anticancer therapy has been successfully designed with liposome-based nanomedicine. The liposomal formulation in cancer drug delivery can be facilitated with a functionalized peptide that mediates the specific drug delivery opportunities with increased drug penetrability, specific accumulation in the targeted site, and enhanced therapeutic efficacy. This review aims to focus on recent advances in peptide-functionalized liposomal formulation techniques in cancer diagnosis and treatment regarding recently published literature. It also will highlight different aspects of novel liposomal formulation techniques that incorporate surface functionalization with peptides for better anticancer effect and current challenges in peptide-functionalized liposomal drug formulation.

Keywords: Peptide; active targeting; bio-nanoparticle; cancer; diagnostic liposomes; liposome; nanotechnology; peptide-functionalized liposome.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Liposomes / therapeutic use
  • Neoplasms* / drug therapy
  • Peptides / therapeutic use

Substances

  • Antineoplastic Agents
  • Liposomes
  • Peptides